![Richard Fair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Fair
Directeur Général chez
ENLIVEN THERAPEUTICS, INC.
Profil
Mr. Richard A. Fair is a Chief Executive Officer & Director at Enliven Therapeutics, Inc. /US/, a President, Chief Executive Officer & Director at Enliven Therapeutics, Inc. and a President & Director at Bellicum Pharmaceuticals, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. /US/, Enliven Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. Mr. Fair was previously employed as an Independent Director by Clovis Oncology, Inc., a SVP & Head-Therapeutic Oncology Global Product by Genentech, Inc., and a Franchise Head-Hematology by Roche Pharma (Schweiz) AG.
He received his undergraduate degree from the University of Michigan and an MBA from Columbia Business School.
Postes actifs de Richard Fair
| Sociétés | Poste | Début |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | President | 31/01/2017 |
| ENLIVEN THERAPEUTICS, INC. | Directeur Général | 11/12/2025 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Directeur Général | 11/12/2025 |
Anciens postes connus de Richard Fair
| Sociétés | Poste | Fin |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 10/07/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2017 |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Formation de Richard Fair
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
Choisissez Zonebourse 
